Traditional eye drops are antiquated and inadequate
40M+ people in the United States wear soft contact lenses which are incompatible with daily eye drop treatments.
Our solution is unique, and potentially a future standard of care
We use our proprietary MediPrint™ process and will initially develop, clinically test and commercialize drug-eluting, comfort-enhancing contact lenses to treat millions of contact lens patients worldwide suffering from glaucoma, dry eye and ocular allergy.
FDA Approved Drug